Ligand validation:3LEO

LMT: DODECYL-BETA-D-MALTOSIDE

LMT is a Ligand Of Interest in 3LEO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3LEO_LMT_A_213	1%	46%	0.333	0.538	0.78	1.29	-	7	4	0	100%	1
3PCV_LMT_A_212	40%	74%	0.074	0.944	0.35	0.65	-	-	0	0	11%	11.43
2PNO_LMT_G_222	16%	83%	0.265	0.972	0.24	0.54	-	-	3	0	26%	0.2571
2UUI_LMT_A_1155	12%	60%	0.278	0.814	0.66	0.87	1	1	2	0	100%	1
6R7D_LMT_B_209	9%	55%	0.301	0.791	0.69	1.05	1	1	0	0	100%	1
5NV9_LMT_A_504	99%	31%	0.045	0.983	0.57	2.12	-	12	1	0	100%	1
3CAY_LMT_A_512	94%	59%	0.071	0.968	0.66	0.9	-	1	0	0	100%	1
4U8Y_LMT_C_1101	83%	64%	0.096	0.953	0.43	0.92	-	1	2	0	100%	1
3SZF_LMT_A_501	73%	33%	0.101	0.928	1.23	1.44	3	5	2	0	100%	1
3T14_LMT_A_501	72%	31%	0.12	0.945	1.21	1.54	3	10	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.